Financhill
Sell
50

CE Quote, Financials, Valuation and Earnings

Last price:
$57.19
Seasonality move :
10.65%
Day range:
$56.87 - $58.68
52-week range:
$45.94 - $172.16
Dividend yield:
3.64%
P/E ratio:
7.03x
P/S ratio:
0.62x
P/B ratio:
1.24x
Volume:
2.1M
Avg. volume:
3.8M
1-year change:
-63.95%
Market cap:
$6.4B
Revenue:
$10.3B
EPS (TTM):
-$13.93

Earnings Data

Next earnings date for CE
May 08
2025
Most recent earnings per share
-$17.50
Missed by $18.70
(Feb 18/2025)
Consensus Estimate
$1.20
(Feb 18/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CE Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/08/2025 Q1 $2.3B -- -- $0.46 --
02/18/2025 Q4 $2.4B $2.4B -$17.50 $1.20 -$18.70
11/05/2024 Q3 $2.7B $2.6B $1.06 $2.84 -$1.78
08/01/2024 Q2 $2.7B $2.7B $1.41 $2.74 -$1.33
05/08/2024 Q1 $2.7B $2.6B $1.10 $1.91 -$0.81
02/20/2024 Q4 $2.6B $2.6B $6.37 $2.31 $4.06
11/06/2023 Q3 $2.8B $2.7B $8.69 $2.23 $6.46
08/07/2023 Q2 $3B $2.8B $2.01 $2.48 -$0.47
05/10/2023 Q1 $2.9B $2.9B $0.83 $1.63 -$0.80
02/24/2023 Q4 $2.4B $2.3B $7.02 $1.65 $5.37
11/04/2022 Q3 -- $2.3B $1.75 -- --
07/28/2022 Q2 -- $2.5B $3.98 -- --
04/29/2022 Q1 -- $2.5B $4.61 -- --
01/27/2022 Q4 -- $2.3B $4.79 -- --
10/21/2021 Q3 -- $2.3B $4.56 -- --
07/22/2021 Q2 -- $2.2B $4.77 -- --
04/22/2021 Q1 -- $1.8B $2.82 -- --
01/28/2021 Q4 -- $1.6B $12.50 -- --
10/25/2020 Q3 -- $1.4B $1.75 -- --
07/28/2020 Q2 -- $1.2B $0.90 -- --
04/28/2020 Q1 -- $1.5B $1.82 -- --
01/30/2020 Q4 -- $1.4B $0.36 -- --
10/21/2019 Q3 -- $1.6B $2.13 -- --
07/22/2019 Q2 -- $1.6B $1.66 -- --
04/22/2019 Q1 -- $1.7B $2.63 -- --
01/28/2019 Q4 -- $1.7B $0.75 -- --
10/19/2018 Q3 -- $1.8B $2.96 -- --
07/20/2018 Q2 -- $1.8B $2.52 -- --
04/17/2018 Q1 -- $1.9B $2.66 -- --
01/26/2018 Q4 -- $1.6B $1.49 -- --
10/17/2017 Q3 -- $1.6B $1.65 -- --
07/25/2017 Q2 -- $1.5B $1.66 -- --
04/18/2017 Q1 -- $1.5B $1.30 -- --
02/01/2017 Q4 -- $1.3B $1.13 -- --
10/18/2016 Q3 -- $1.3B $1.81 -- --
07/26/2016 Q2 -- $1.4B $1.50 -- --
04/19/2016 Q1 -- $1.4B $1.73 -- --
01/22/2016 Q4 -- $1.3B -$1.94 -- --
10/20/2015 Q3 -- $1.4B $1.07 -- --
07/17/2015 Q2 -- $1.5B $1.33 -- --
04/17/2015 Q1 -- $1.5B $1.53 -- --

Celanese Earnings Questions

  • How Much did Celanese Generate in Revenue Last Quarter?

    Celanese reported $2.4B worth of top line sales in its most recent quarter.

  • Did Celanese Beat Earnings Last Quarter?

    Celanese announced earnings per share of -$17.50 which represents a miss of analyst forecast a $1.20 per share.

  • Is Celanese Profitable?

    Celanese reported $539M that represents $4.93 per share over the last quarter.

  • What is the Analyst Consensus for Celanese EPS Next Year?

    Celanese's earnings are forecast to decrease from -$13.93 per share to $8.10 per share next year representing a decrease of -54.8%.

  • When is Celanese's Earnings Date?

    Celanese's next earnings date is May 8, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Alphabet Stock No Longer a Good Bet?
Is Alphabet Stock No Longer a Good Bet?

Alphabet tripled its price per share over the past 5…

Pepsi Vs Coke Stock: Which Is Best?
Pepsi Vs Coke Stock: Which Is Best?

Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Sell
48
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
52
RGC alert for Mar 19

Regencell Bioscience Holdings [RGC] is down 0.66% over the past day.

Sell
49
SRPT alert for Mar 19

Sarepta Therapeutics [SRPT] is up 8.72% over the past day.

Sell
46
CVNA alert for Mar 19

Carvana [CVNA] is up 5.74% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock